Diagnosis of Suspected Precursor-Targeted Immune-Mediated Anemia (PIMA) in a Cat with Prolonged Anemia: A Case Report

다국어 초록 (Multilingual Abstract)

The immune-mediated destruction of erythroid precursors within the bone marrow can result in inefficient erythropoiesis, classified as precursor-targeted immune-mediated anemia (PIMA). Herein, we describe the case of a 1-year-old Scottish Fold cat who presented with a pale mucous membrane with a history of prior diagnosis with immune mediated hemolytic anemia (IMHA), characterized by normocytic normochromic moderate anemia. The cat was administered six months of immunosuppressive therapy, including prednisolone, cyclosporine, or mycophenolate mofetil, but exhibited insufficient reticulocytosis. Bone marrow examination subsequently revealed a decreased myeloid to erythroid ratio of 0.35:1, and PIMA was diagnosed. Treatment modification with chlorambucil was implemented, and the cat remained well-managed without IMHA recurrence for 15 months. This case highlights the importance of careful evaluation methods, such as reviewing medication history and performing bone marrow examinations, in IMHA patients with an insufficient response to immunosuppressive therapy. These results further suggest the occasional need for medication adjustments during treatment.

참고문헌 (Reference)

1 Doyun Kim ; Woo-Jin Song ; Sung-Soo Kim ; Soyoung Jeong ; Hyun Jeong Hong ; Youngmin Yun, "Successful long-term management of late-stage precursor-targeted immune-mediated anemia with prednisolone and mycophenolate mofetil in a dog" 63 : e8-, 2023

2 Turinelli V, "Retrospective study of 152 feline cytological bone marrow examinations : preliminary classification and ranges" 20 : 1158-1168, 2018

3 Kohn B, "Primary immune-mediated hemolytic anemia in 19 cats : diagnosis, therapy, and outcome(1998-2004)" 20 : 159-166, 2006

4 Akiyoshi M, "Presumptive precursor-targeted immune-mediated anemia concurrent with gastrointestinal lymphoma in a cat" 82 : 1570-1576, 2020

5 Stokol T, "Idiopathic pure red cell aplasia and nonregenerative immune-mediated anemia in dogs : 43 cases(1988-1999)" 216 : 1429-1436, 2000

6 Black V, "Feline non-regenerative immune-mediated anaemia : features and outcome in 15cases" 18 : 597-602, 2016

7 Olson SW, "Feline non-regenerative anemia : diagnostic and treatment recommendations" 21 : 615-631, 2019

8 Swann JW, "Demographic characteristics, survival and prognostic factors for mortality in cats with primary immune-mediated hemolytic anemia" 30 : 147-156, 2016

9 Maldonado-Moreno A, "Clinical findings, treatment and outcome in cats diagnosed with precursor-targeted immune-mediated anaemia in a referral hospital in the UK : 30 cases(2010-2021)" 10 : e70-, 2023

10 Assenmacher TD, "Clinical features of precursor-targeted immune-mediated anemia in dogs : 66 cases(2004-2013)" 255 : 366-376, 2019

11 Weiss DJ, "Bone marrow pathology in dogs and cats with non-regenerative immune-mediated haemolytic anaemia and pure red cell aplasia" 138 : 46-53, 2008